University of Pittsburgh Cancer Institute (UPCI)

Overview

Investigators within the Radiation Oncology Disease Site are developing and testing innovative technologies, in addition to evaluating novel applications of existing technologies, to maximize the chance of cure and minimize the risk of treatment-related toxicities and to advance the field of radiation oncology. The coordination of three divisions within the Disease Site (basic science research, physics, and clinical services) enables more advanced and higher quality services to patients.

• The Basic Science Research Division develops methods to treat acute and chronic side effects of radiation therapy. Current studies are focusing on the development of new small molecule radioprotectors and stem cell transplant techniques for organ protection — prior to radiation treatment and organ reconstitution following radiation treatment.
• The Physics Division coordinates and streamlines communication of treatment plans and quality assurance documentation between physicists and physicians at 21 radiotherapy practice sites in the United States and two international sites in Ireland.
• The Clinical Services Division ensures the highest quality radiation oncology treatments are provided to patients on UPCI protocols. This level of care also extends to patients at community cancer centers participating in clinical pathways developed within the University of Pittsburgh Department of Radiation Oncology.